{"id":13776,"date":"2019-06-11T10:40:55","date_gmt":"2019-06-11T09:40:55","guid":{"rendered":"http:\/\/www.lihnnhs.info\/Sando\/?p=13776"},"modified":"2019-06-11T10:40:55","modified_gmt":"2019-06-11T09:40:55","slug":"knowledge-lert-for-tuesday-11th-june","status":"publish","type":"post","link":"https:\/\/www.lihnnhs.info\/Sando\/2019\/06\/11\/knowledge-lert-for-tuesday-11th-june\/","title":{"rendered":"Knowledge @lert for Tuesday 11th June"},"content":{"rendered":"
\n

Frailty toolkit<\/strong><\/p>\n

NHS RightCare has published the NHS RightCare Frailty Toolkit<\/a>.\u00a0 The toolkit provides expert practical advice and guidance on how to commission and provide the best system wide care for people living with frailty.\u00a0 It will support systems to understand the priorities in frailty identification and care, and key actions to take.\u00a0 It also provides a way to assess and benchmark current systems to find opportunities for improvement.<\/p>\n

\n

NICE guidance<\/strong><\/p>\n

Technology appraisal guidance<\/strong><\/p>\n\n\n\n\n
TA583<\/td>\nErtugliflozin with metformin and a dipeptidyl peptidase-4 inhibitor for treating type 2 diabetes<\/a><\/td>\n<\/tr>\n
TA584<\/td>\nAtezolizumab in combination for treating metastatic non-squamous non-small-cell lung cancer<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n
\n

The future of eye care<\/strong><\/p>\n

Reform has published The future of eye care: building on NHS reform success<\/a>.\u00a0 This briefing provides an overview of policy developments in the eye care sector.\u00a0 It also addresses the cutting-edge technologies that are coming into use in the eye care sector, which further evidences its key role in driving forward modernisation in the service.<\/p>\n

\n

Biosimilar Medicine<\/strong><\/p>\n

NHS England has published What is biosimilar medicine?<\/a>\u00a0 This document provides an update for key clinical and non-clinical stakeholders about the role of biosimilar medicines in the NHS in England and to support the safe, effective and consistent use of all biological medicines, including biosimilar medicines, to the benefit of patients.<\/p>\n

\n

NHS People Plan – additional resources<\/strong><\/p>\n

Following on from yesterday\u2019s publication of the Interim NHS People Plan, NHS England has published a summary of engagement with stakeholders to date, as well as further information regarding specific groups of NHS staff<\/a>.<\/p>\n

In addition, NHS England has published a speech from the Secretary of State for Health on the launch of the NHS People Plan<\/a>.<\/p>\n

The following blogs and briefing relating to the NHS People Plan have also been published:<\/p>\n